Written informed consent obtained from the patient/parents or legal representative;
Adequate hematological function (leucocyte ≥ 2.0 x 10\^9/l -Hemoglobin ≥ 10 g/dl - platelet ≥ 50 x 10\^9 /l);
Adequate liver function (total bilirubin ≤ 2.5 x ULN - ALT/AST ≤ 5.0 x ULN);
Adequate renal function (serum creatinine ≤ 1.5 x ULN);
Adherence to trial treatment and compliance with the protocol
You may not be if
Any disease or condition that contraindicates the use of the study drug (es. serious mental retardation, brain palsy, congenital syndrome, cardiomyopathy)
